Thorn L - Search Results

1

The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.

Bristow LJ, Hutson PH, Thorn L, Tricklebank MD. Bristow LJ, et al. Among authors: thorn l. Br J Pharmacol. 1993 Apr;108(4):1156-63. doi: 10.1111/j.1476-5381.1993.tb13520.x. Br J Pharmacol. 1993. PMID: 8485625 Free PMC article.

2

R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine.

Hutson PH, Bristow LJ, Thorn L, Tricklebank MD. Hutson PH, et al. Among authors: thorn l. Br J Pharmacol. 1991 Aug;103(4):2037-44. doi: 10.1111/j.1476-5381.1991.tb12372.x. Br J Pharmacol. 1991. PMID: 1655150 Free PMC article.

3

Behavioural and biochemical evidence of the interaction of the putative antipsychotic agent, BMY 14802 with the 5-HT1A receptor.

Bristow LJ, Baucutt L, Thorn L, Hutson PH, Noble A, Beer M, Middlemiss DN, Tricklebank MD. Bristow LJ, et al. Among authors: thorn l. Eur J Pharmacol. 1991 Oct 29;204(1):21-8. doi: 10.1016/0014-2999(91)90830-j. Eur J Pharmacol. 1991. PMID: 1839533

4

Competitive NMDA receptor antagonists attenuate the behavioural and neurochemical effects of amphetamine in mice.

Bristow LJ, Thorn L, Tricklebank MD, Hutson PH. Bristow LJ, et al. Among authors: thorn l. Eur J Pharmacol. 1994 Nov 3;264(3):353-9. doi: 10.1016/0014-2999(94)00491-9. Eur J Pharmacol. 1994. PMID: 7698176

5

The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex.

Tricklebank MD, Bristow LJ, Hutson PH, Leeson PD, Rowley M, Saywell K, Singh L, Tattersall FD, Thorn L, Williams BJ. Tricklebank MD, et al. Among authors: thorn l. Br J Pharmacol. 1994 Nov;113(3):729-36. doi: 10.1111/j.1476-5381.1994.tb17054.x. Br J Pharmacol. 1994. PMID: 7858861 Free PMC article.

6

Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.

Bristow LJ, Hutson PH, Kulagowski JJ, Leeson PD, Matheson S, Murray F, Rathbone D, Saywell KL, Thorn L, Watt AP, Tricklebank MD. Bristow LJ, et al. Among authors: thorn l. J Pharmacol Exp Ther. 1996 Nov;279(2):492-501. J Pharmacol Exp Ther. 1996. PMID: 8930150

7

Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptors.

Thorn L, Ashmeade TE, Storey VJ, Routledge C, Reavill C. Thorn L, et al. Neuropharmacology. 1997 Jun;36(6):787-92. doi: 10.1016/s0028-3908(97)00033-6. Neuropharmacology. 1997. PMID: 9225306

8

Elucidation of D3 receptor function in vivo: do D3 receptors mediate inhibition of dopamine neuronal activity?

Routledge C, Thorn L, Ashmeade T, Taylor S. Routledge C, et al. Among authors: thorn l. Biochem Soc Trans. 1996 Feb;24(1):199-201. doi: 10.1042/bst0240199. Biochem Soc Trans. 1996. PMID: 8674661 No abstract available.

9

Stroke incidence increases with diabetic retinopathy severity and macular edema in type 1 diabetes.

Eriksson MI, Hietala K, Summanen P, Harjutsalo V, Putaala J, Ylinen A, Hägg-Holmberg S, Groop PH, Thorn LM; FinnDiane Study. Eriksson MI, et al. Among authors: thorn lm. Cardiovasc Diabetol. 2024 Apr 25;23(1):136. doi: 10.1186/s12933-024-02235-w. Cardiovasc Diabetol. 2024. PMID: 38664827

10

Live music in the intensive care unit - a beautiful experience.

Dreyer P, Thorn L, Lund TH, Bro ML. Dreyer P, et al. Among authors: thorn l. Int J Qual Stud Health Well-being. 2024 Dec;19(1):2322755. doi: 10.1080/17482631.2024.2322755. Epub 2024 Feb 29. Int J Qual Stud Health Well-being. 2024. PMID: 38422091 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page